Live birth and miscarriage rate following intracytoplasmic morphologically selected sperm injection vs intracytoplasmic sperm injection: An updated systematic review and meta‐analysis
- 30 August 2019
- journal article
- review article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 99 (1) , 24-33
Abstract
Introduction: Intracytoplasmic morphologically selected sperm injection (IMSI) is one of the sperm selection techniques used for assisted reproduction which has been applied for a variety of indications including previously failed fertilization with intracytoplasmic sperm injection (ICSI). A Cochrane review1 found no difference in outcomes between either modality of sperm selection. Since the Cochrane review was published there have been a further two randomized controlled trials comparing IMSI and ICSI. This systematic review and meta‐analysis aims to compare IMSI with ICSI as insemination methods regarding live birth rate and miscarriage rate.Material and methods: Systematic review of randomized controlled trials, observational studies and similar reviews in electronic databases published before January 2018.Results: We found nine randomized controlled trials, evaluating 1610 cycles of in vitro fertilization and 15 observational studies evaluating 1243 cycles of in vitro fertilization. Meta‐analysis of the included randomized controlled trials showed no difference in the live birth rate or miscarriage rate between the ICSI and IMSI groups. Meta‐analysis of five observational studies showed a significantly higher number of live births in the IMSI group than ICSI group (live birth rate odds ratio 1.47, 95% confidence interval 1.16‐4.07), with a moderate degree of heterogeneity (I2 = 41%). Additionally, from six observational studies, a significantly lower miscarriage rate was observed in the IMSI group than in the ICSI group (odds ratio 0.51, 95% confidence interval 0.37‐0.70, I2 = 0%).Conclusions: Meta‐analysis of randomized studies comparing IMSI to ICSI has not shown any difference in live birth rate and miscarriage rate. Meta‐analysis of observational studies, which must be interpreted with caution, revealed an increased live birth rate and decreased miscarriage rate with IMSI vs ICSI.Keywords
This publication has 43 references indexed in Scilit:
- Intracytoplasmic morphologically selected sperm injection (IMSI): a critical and evidence-based reviewBasic and Clinical Andrology, 2013
- Sperm vacuoles negatively affect outcomes in intracytoplasmic morphologically selected sperm injection in terms of pregnancy, implantation, and live-birth ratesFertility and Sterility, 2013
- Is intracytoplasmic morphologically selected sperm injection (IMSI) beneficial in the first ART cycle? A multicentric randomized controlled trialAndrology, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Pregnancy outcomes in women with repeated implantation failures after intracytoplasmic morphologically selected sperm injection (IMSI)Reproductive Biology and Endocrinology, 2011
- The IMSI procedure improves poor embryo development in the same infertile couples with poor semen quality: A comparative prospective randomized studyReproductive Biology and Endocrinology, 2011
- Intracytoplasmic injection of morphologically selected spermatozoa (IMSI) improves outcome after assisted reproduction by deselecting physiologically poor quality spermatozoaJournal of Assisted Reproduction and Genetics, 2010
- Efficiency of hyaluronic acid (HA) sperm selectionJournal of Assisted Reproduction and Genetics, 2009
- Increased Aneuploidy Rate in Sperm With Fragmented DNA as Determined by the Sperm Chromatin Dispersion (SCD) Test and FISH AnalysisJournal of Andrology, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002